Inhibiting miR-33b-5p Enhances Chemoresistance in Lung Adenocarcinoma by Targeting YWHAH to Regulate Epithelial-mesenchymal Transition
Anticancer Research · 2023
DOI: 10.21873/anticanres.16748 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2023. Verfasst von Bin Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Zhongda Hospital, School of Medicine, Southeast University, Nanjing City, P.R. China 101012225@seu.edu.cn. Hauptthemen laut MEDLINE: MicroRNAs, Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiothoracic Surgery, Zhongda Hospital, School of Medicine, Southeast University, Nanjing City, P.R. China 101012225@seu.edu.cn.
- Department of Cardiothoracic Surgery, Zhongda Hospital, School of Medicine, Southeast University, Nanjing City, P.R. China.
- Department of Cardiothoracic Surgery, Zhongda Hospital, School of Medicine, Southeast University, Nanjing City, P.R. China xt_zdyy_cs@163.com.
Zitieren
APA
Liu, B., Pu, Z. Y., Wang, L., Fang, J., & Xue, T. (2023). Inhibiting miR-33b-5p Enhances Chemoresistance in Lung Adenocarcinoma by Targeting YWHAH to Regulate Epithelial-mesenchymal Transition. Anticancer Research. https://doi.org/10.21873/anticanres.16748
Vancouver
Liu B, Pu ZY, Wang L, Fang J, Xue T. Inhibiting miR-33b-5p Enhances Chemoresistance in Lung Adenocarcinoma by Targeting YWHAH to Regulate Epithelial-mesenchymal Transition. Anticancer Research. 2023. doi:10.21873/anticanres.16748
BibTeX
@article{Liu2023,
author = {Liu, Bin and Pu, Zhen-Ye and Wang, Lei and Fang, Jin and Xue, Tao},
title = {Inhibiting miR-33b-5p Enhances Chemoresistance in Lung Adenocarcinoma by Targeting YWHAH to Regulate Epithelial-mesenchymal Transition},
journal = {Anticancer Research},
year = {2023},
doi = {10.21873/anticanres.16748}
}
EUVIMED